Monoamine oxidase inhibitors (MAOI) are identified to extend and greatly enhance the consequences of dimethyltryptamine (copyright) and one particular review assumed that the impact on psilocybin will be equivalent as it is usually a structural analogue of copyright.[a hundred forty five] Nevertheless, only a little part of psilocin appears to gene